Out-of-Pocket Costs Similar for Infliximab, Infliximab-Dyyb

Share this content:
Out-of-Pocket Costs Similar for Infliximab, Infliximab-Dyyb
Out-of-Pocket Costs Similar for Infliximab, Infliximab-Dyyb

WEDNESDAY, Sept. 5, 2018 (HealthDay News) -- Under Medicare Part D, out-of-pocket costs are similar for infliximab and its biosimilar infliximab-dyyb, according to a research letter published in the Sept. 4 issue of the Journal of the American Medical Association.

Jinoos Yazdany, M.D., M.P.H., from the University of California in San Francisco, and colleagues calculated the mean total cost and out-of-pocket cost requirements for infliximab-dyyb and infliximab assuming a standard eight-week dosing regimen. These national means were used to project maximum annual out-of-pocket costs if beneficiaries used each drug and no other prescriptions under a standard 2017 Part D benefit. As part of Part D, beneficiaries receive a discount during the coverage gap for brand-name drugs and biologics but not for biosimilars.

The researchers found that fewer plans covered infliximab-dyyb than infliximab (10 versus 96 percent of the 2,547 plans). The mean total cost per eight-week prescription and annually was modestly lower for infliximab-dyyb ($2,185 versus $2,667 and $14,202 versus $17,335, respectively). For infliximab-dyyb, plans universally required coinsurance cost-sharing; coinsurance rates were similar to infliximab (26.6 versus 28.4 percent of drug cost, respectively). Projected annual out-of-pocket costs were higher for infliximab-dyyb than for infliximab without gap discounts ($5,118 versus $3,432).

"Although biosimilar gap discounts begin in 2019, infliximab-dyyb may still not significantly reduce Part D beneficiaries' out-of-pocket costs given its high price and coinsurance cost-sharing similar to infliximab," the authors write.

One author disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Compression Collar May Protect Brain of Female Soccer Players

Compression Collar May Protect Brain of Female Soccer ...

No white matter changes among female high school soccer athletes who wore compression collar

Fertility Rates Down for Each Urbanization Level 2007 to 2017

Fertility Rates Down for Each Urbanization Level 2007 ...

Fertility rates decreased from 2007 to 2017 with larger decreases in metro versus rural counties

Lung Cancer Deaths 28 Lower in California Than Rest of U.S.

Lung Cancer Deaths 28% Lower in California Than ...

Among those aged 18 to 35, California has had larger drops in smoking initiation, intensity, more quitting

is free, fast, and customized just for you!




Already a member?

Sign In Now »